Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

NCT07430956 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

2628

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation (AF)

Interventions

DRUG: REGN7508
DRUG: REGN9933
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals